JUN 10, 2015 07:30 AM PDT

The Future of Laboratory Reimbursements

  • Executive Vice President Emeritus, ASCLS
      Elissa Passiment is the Executive Vice President of the American Society for Clinical Laboratory Science (ASCLS). She is a clinical laboratory scientist with over twenty years experience in clinical laboratories as staff, educator and manager and another twenty years in health care consulting, association management and health policy. Ms. Passiment uses her science background and experience to analyze policies and systems as they relate to the future of health care, its changing emphasis, reimbursement, patient safety, quality delivery and business potential. She has served on the congressionally mandated Negotiated Rulemaking Committee convened to standardize and simplify reimbursement for laboratory services under Medicare Part B; presented testimony to Institute of Medicine studies, and represents ASCLS at meetings with the FDA, CMS, and CDC. She is also on the Editorial Board of Lab Tests Online. She was a member of the Clinical Laboratory Improvement Advisory Committee (CLIAC) from 2007-2011 and served as Chair for 2009-11. She is the recipient of numerous awards, including the Laboratory Public Service National Leadership Award.

    CMS continues to make changes to how all healthcare providers are reimbursed in attempts to control the cost of the services provided to Medicare beneficiaries. This has led to value-based reimbursement, quality measures and "packaging" of service payments. CMS is also charged with recalculating the clinical laboratory fee schedule, which may or may not be important depending on how we are paid for our services. We will look at these trends and discuss their impact on how we take care of our patients.

    Show Resources
    Loading Comments...